Voleon Capital Management LP Gilead Sciences, Inc. Transaction History

Voleon Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $4.5 Million - $5.13 Million	-75,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $4.25 Million - $4.84 Million	75,000 New	75,000 $4.37 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $21.9 Million - $24.5 Million	-350,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $21.2 Million - $27.7 Million	350,000 New	350,000 $21.9 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Voleon Capital Management LP with notifications on news.